Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: myelodysplastic syndromes

KCL leads first guidelines on immune monitoring for hard-to-treat blood cancer

KCL leads first guidelines on immune monitoring for hard-to-treat blood cancer
p p Read More

Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK

July 16, 2024 blood cancer, immune profiling, immune response, King’s College London, myelodysplastic syndromes, News
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy